Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to COMIRNATY
Related studies linked through entity extraction aliases.
This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.
- Status
- COMPLETED
- Phase
- N/A
Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- N/A
A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1
Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose
- Status
- UNKNOWN
- Phase
- PHASE2
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine
- Status
- UNKNOWN
- Phase
- PHASE2
COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
- Status
- TERMINATED
- Phase
- PHASE4
Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19
- Status
- COMPLETED
- Phase
- PHASE1